Term Sheet Red Flags: When to Walk Away From a Deal
Most of a term sheet, roughly 80% to 90% of its clauses, is standard boilerplate that barely varies between funds at a given stage. The 10% to 20% that does vary is where real red flags live: uncapped participating preferred stock, full ratchet anti-dilution, board control disproportionate to owners
Author: Yanni Papoutsis · Fractional VP of Finance and Strategy for early-stage startups · Author, Raise Ready
Published: 2026-06-10 · Last updated: 2026-06-10
Reading time: ~10 min
What Is Driver-Based Revenue Forecasting?
A revenue forecast is a projection of the money your business will earn over a defined future period. There are two ways to build one:
Top-down forecasting starts with the total addressable market and works down to a market share assumption: “The UK B2B software market is worth £10 billion. If we capture 0.1%, we generate £10 million in revenue.” Useful for sizing the opportunity, useless for operational planning. Investors have heard thousands of 0.1% market share projections and are rightly sceptical.
Bottom-up, driver-based forecasting starts with the specific activities that generate revenue: “We have capacity to run 20 outbound sales conversations per week. Our conversion rate is 10%. Our average contract value is £12,000 per year. That gives us 2 new customers per week, or roughly 100 new customers per year, generating £1.2 million in new ARR.” Every assumption in that chain is testable, improvable, and explainable.
Driver-based forecasting is also the input layer for your 3-statement model — your revenue drivers feed the income statement, which integrates with the balance sheet and cash flow statement.
Why a Revenue Forecast Startup Needs a Different Approach
Established businesses forecast revenue by extrapolating historical data. Startups do not have historical data. The entire forecast must be built on forward-looking assumptions rather than trend lines. A driver-based model built on transparent assumptions is actually more useful to an early-stage investor than a statistical extrapolation, because it makes the business logic explicit and discussable.
The Core Framework: Identify Your Revenue Drivers
What Percentage of Term Sheet Terms Are Actually Standard?
Most of a term sheet at a given stage looks nearly identical across funds: a 1x non-participating liquidation preference, board composition proportional to ownership, standard protective provisions, pro-rata rights for future rounds, and a typical four-year vesting schedule with a one-year cliff. This is not an argument for complacency, since the standard terms still deserve a careful read to confirm they truly are standard and haven't been quietly modified, but it does mean your limited time and social capital in the negotiation are better spent on the handful of clauses that actually vary. Founders who treat every clause as equally negotiable waste energy on points that rarely move and miss the handful of clauses that actually matter. Read the complete term sheet bible once, in full, before your first term sheet arrives, so you already know which 10% to 20% of the document deserves your full attention.
Is a Participating Preferred Liquidation Preference a Red Flag?
This single clause, more than almost any other line in a term sheet, determines how a modest or middling exit actually gets split between investors, founders, and the employee option pool, which is exactly why it deserves outsized attention relative to how little space it usually takes up on the page.
Standard is 1x non-participating: in an exit, the investor takes the greater of their liquidation preference or their as-converted common share, but not both. Participating preferred lets the investor take the preference and then also share pro rata in whatever's left, a structure often called a double dip. A capped participating preference (for example, capped at 2x to 3x total return) is a middle ground sometimes seen in later or riskier rounds.
The dollar impact is real. In a mid-size exit, say a $30M sale on a company that raised $5M at a $15M post-money with 1x participating preferred and no cap, the investor's take can be materially higher than under a standard non-participating structure, often enough to meaningfully shrink what's left for founders and the employee pool. See the full math in our guides to liquidation preference and waterfall analysis. Uncapped participating preferred on an early-stage round, with no competing pressure forcing your hand, is a legitimate reason to push back hard or walk.
Is Full Ratchet Anti-Dilution a Deal Breaker?
Broad-based weighted average anti-dilution is standard and reasonably fair: it adjusts the investor's conversion price to reflect a down round, weighted by how much new stock was actually issued. Full ratchet is far more punitive: it resets the investor's price to match the new, lower round price entirely, regardless of how small that new round was, which can devastate founder and employee ownership if a down round ever happens. See the full comparison in our guide to anti-dilution provisions and how the math plays out in a down round scenario. Full ratchet from a standard venture investor, outside of true rescue financing from a lender of last resort, is one of the clearest legitimate walk-away red flags on this list.
What Founder Vesting and Control Terms Should Worry You?
Investors sometimes ask founders to re-vest already-vested shares under a new schedule. This is negotiable and not automatically a red flag, but it should never apply to your full pre-vested stake, and it should always come with acceleration triggers (single or double trigger on a sale or termination without cause). Watch closely for removal-without-cause provisions that let the board push out a founder with limited protection, board seats for a single investor that are disproportionate to their ownership stake, and protective provisions stacked so broadly that ordinary operating decisions require investor sign-off. Review founder vesting schedule standards so you know exactly what's typical before you agree to anything unusual.
What Cap Table and Pool Red Flags Should You Check Before Signing?
Confirm exactly how the option pool is sized and whether it's added pre-money or post-money; a pre-money pool dilutes only existing shareholders, which is one of the more overlooked negotiation points in a term sheet. Check for hidden dilution from stacked SAFEs that changes the real ownership math once everything converts. Confirm your 409A valuation is current, and confirm there are no undisclosed side letters giving one investor materially better terms than what's written in the term sheet itself. Run the full picture through your cap table and your ESOP allocation before you sign, not after.
Is Pressure to Sign Fast Itself a Red Flag?
A normal seed or Series A term sheet negotiation window runs 3 to 10 business days, enough time for your lawyer to review it and for you to ask questions. An "exploding" term sheet demanding signature within 24 to 48 hours, with no clear competitive reason (a genuine competing offer, a fund's internal deadline they can actually explain), is a manufactured urgency tactic designed to prevent you from getting outside counsel or shopping the terms. Compare any unusually fast deadline against the typical term sheet to close timeline to judge whether the pace is normal or a pressure tactic.
When Should You Actually Walk Away?
Walk away, or at minimum pause and get outside counsel involved immediately, if you see any of the following: uncapped participating preferred stock, full ratchet anti-dilution, board control disproportionate to the investor's ownership stake, outright unwillingness to let your lawyer review or negotiate the document at all, a valuation so low it functions as an undisclosed down round, or poor results from reference checks on the fund itself. Your leverage to walk away is directly tied to your runway; check your runway calculator before the negotiation so you know precisely how much time you actually have to hold firm. Contrast this with terms genuinely worth negotiating but not worth walking over: the exact scope of pro-rata rights, information rights details, or minor board observer seat terms. Knowing the difference between these two categories is what separates a founder who negotiates effectively from one who either signs anything or torches a deal over a non-issue.
What Should You Do Instead of Signing a Bad Term Sheet?
Bring data and comps to negotiate the specific clause directly rather than rejecting the whole term sheet outright. If you have any leverage, use a competing term sheet to force a change. Ask your lawyer for a markup with specific alternative language rather than a vague objection. Consider whether short-term financing via a SAFE or convertible note from existing investors might buy you time to find a cleaner deal instead of accepting bad terms under pressure. And if none of that works, genuinely walking away and continuing the raise is always the last, real option, one that's easier to take seriously when you've been tracking a full pipeline of other investors all along rather than betting everything on a single term sheet. Whichever path you choose, document the specific terms you pushed back on and why, since that record is useful both for your own future negotiations and for comparing how different funds in your pipeline actually respond under pressure.
Frequently Asked Questions
Is participating preferred always a bad sign? Not always. Capped participating preferred shows up more often in later or higher-risk rounds and is generally more acceptable than in an early-stage deal. Uncapped participating preferred on an early round, without competitive pressure forcing it, is the version worth pushing back on hardest.
What's the difference between broad-based and full ratchet anti-dilution? Broad-based weighted average adjusts the investor's conversion price proportionally to how much new stock was issued in a down round. Full ratchet resets the price entirely to the new round's price regardless of size, which is far more punitive to founders and employees.
How long should I have to review a term sheet before signing? A normal window is 3 to 10 business days. Anything demanding signature in under 48 hours without a clear, explainable reason deserves real scrutiny.
Can I negotiate a term sheet after signing it? The term sheet itself is typically non-binding on price and most terms, except for exclusivity, confidentiality, and no-shop clauses, which usually are binding once signed. Definitive documents drafted after the term sheet remain negotiable, though within the framework already agreed.
Should I always use a lawyer to review a term sheet? Yes. Even a standard-looking term sheet benefits from experienced venture counsel review, and any fund unwilling to give you time for that review is itself a signal worth taking seriously.
Before you sign anything, model the real economic outcome under different scenarios using your cap table and our financial model tool, so the number you're negotiating against is your own, not just the one on the page.
Further Reading
Get the complete guide with all 16 chapters, exercises, and model templates.
Get Raise Ready - $9.99